Carl Zeiss: Revenue Tops Four Billion Euro Mark for Very First Time
Carl Zeiss ended fiscal year 2010/11 (reporting date: 30 September 2011) with a clear increase in revenue and earnings over the prior year: with a total of EUR 4.237b, revenue topped the four billion euro mark for the very first time (prior year: EUR 2.981b). Earnings (EbIT) totaled EUR 607m (prior year: EUR 423m). The positive development in business, bolstered by a favorable trend in the economy at the beginning of the past fiscal year, was sustained both by strong organic growth in revenue (ten percent above the prior year) particularly in Asia and America and in the Industrial metrology, Semiconductor Manufacturing Technology and medical technology business groups, and by the full consolidation of the Vision Care business group.
“We have achieved record figures for almost all performance indicators,” said Michael Kaschke, President and CEO of Carl Zeiss. “Carl Zeiss has remained on track to continued profitable and sustained growth and has further consolidated its position as a technology leader and global player.”
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Ocean Optics Names Winner of 2010 Young Investigator Award
Can you analyze me now? Cell phones bring spectroscopy to the classroom
Roche acquires innovatis AG to complement its product portfolio in the rapidly growing area of cellular analytics
Urine samples could be used to predict responses to drugs, say researchers
Abbott enters into agreement with Inpeco to expand laboratory automation capabilites
Phosphorylated Akt isoforms revealed as novel cancer biomarkers by Duolink
Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium - Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture
Roche Diagnostics Supports European Union’s DETECTIVE Project to Reduce Animal Testing
Gerhard Schratt, PhD and Professor Albert Sickmann receive the Analytica Research Prize
Merger of Exeter Analytical and Warwick Analytical Services creates a UK centre of excellence for Elemental Analysis